A comparison of post-COVID vaccine myocarditis classification using the Brighton Collaboration criteria versus Centre for Disease Control criteria.

Marshall, Tessa R; Schrader, Silja; Voss, Laura; Buttery, Jim P; Crawford, Nigel W; Cheng, Daryl R

Marshall, Tessa R; Schrader, Silja; Voss, Laura; Buttery, Jim P; Crawford, Nigel W; Cheng, Daryl R.

Afiliação

Marshall TR; SAEFVIC, Murdoch Children's Research Institute, Parkville.
Schrader S; SAEFVIC, Murdoch Children's Research Institute, Parkville.
Voss L; SAEFVIC, Murdoch Children's Research Institute, Parkville.
Buttery JP; SAEFVIC, Murdoch Children's Research Institute, Parkville.
Crawford NW; Royal Children's Hospital Melbourne, Parkville.
Cheng DR; Department of Paediatrics, University of Melbourne, Parkville.

Commun Dis Intell (2018) ; 472023 01 19.

Article em En | MEDLINE | ID: mdl-36654502

Assuntos

COVID-19; Miocardite; Vacinas Virais; Humanos; Estados Unidos; Vacinas contra COVID-19; Miocardite/epidemiologia; COVID-19/epidemiologia; COVID-19/prevenção & controle; Austrália/epidemiologia; Centers for Disease Control and Prevention, U.S.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 / Miocardite Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 / Miocardite Idioma: En Ano de publicação: 2023 Tipo de documento: Article